Antibiotech
Software for Reducing the Overuse of Antibiotics
Company Overview
Snapshot
Founded in January 2019 by Eran Price and Dr. Uri Keler, Antibiotech operated with 1–10 employees. The company ceased operations in August 2020.
Business overview
Antibiotech develops software designed to combat the misuse and overuse of antibiotics. Its core technology leverages predictive analytics to analyze real-time patient data from electronic medical records, providing prescribing physicians with patient-specific treatment recommendations. These recommendations focus on optimal empiric antibiotic treatments before definitive culture data becomes available. The company's solutions aim to reduce avoidable costs, hospital-acquired infections, and lengths of stay associated with antibiotic overuse, serving the healthcare industry within the Digital Healthcare and Medical Decision Support sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is Antibiotech's primary mission?
- Antibiotech's primary mission is to reduce the misuse and overuse of antibiotics by providing physicians with patient-specific treatment recommendations.
- When was Antibiotech founded?
- Antibiotech was founded in January 2019.
- Who are the founders of Antibiotech?
- Antibiotech was co-founded by Eran Price, who served as CEO, and Dr. Uri Keler, who served as VP Product.
- What technology does Antibiotech utilize?
- Antibiotech utilizes predictive analytics capabilities to analyze real-time patient data from electronic medical records to generate treatment recommendations.
- What was the operational status of Antibiotech?
- Antibiotech ceased to operate in August 2020.